These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 22941207)

  • 21. An Observational Study of the Efficacy of Cisatracurium Compared with Vecuronium in Patients with or at Risk for Acute Respiratory Distress Syndrome.
    Sottile PD; Kiser TH; Burnham EL; Ho PM; Allen RR; Vandivier RW; Moss M;
    Am J Respir Crit Care Med; 2018 Apr; 197(7):897-904. PubMed ID: 29241014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Cisatracurium Versus Atracurium in Early ARDS.
    Moore L; Kramer CJ; Delcoix-Lopes S; Modrykamien AM
    Respir Care; 2017 Jul; 62(7):947-952. PubMed ID: 28351905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Markov computer simulation model of the economics of neuromuscular blockade in patients with acute respiratory distress syndrome.
    Macario A; Chow JL; Dexter F
    BMC Med Inform Decis Mak; 2006 Mar; 6():15. PubMed ID: 16539706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of corticosteroids in the management of acute respiratory distress syndrome.
    Deal EN; Hollands JM; Schramm GE; Micek ST
    Clin Ther; 2008 May; 30(5):787-99. PubMed ID: 18555927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Should ICU patients receive muscle relaxants?
    Coakley J
    Schweiz Med Wochenschr; 1996 Sep; 126(39):1644-8. PubMed ID: 8858758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuromuscular Blocking Agents for ARDS: A Systematic Review and Meta-Analysis.
    Torbic H; Krishnan S; Harnegie MP; Duggal A
    Respir Care; 2021 Jan; 66(1):120-128. PubMed ID: 32843506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intensive care unit-acquired weakness: risk factors and prevention.
    de Jonghe B; Lacherade JC; Sharshar T; Outin H
    Crit Care Med; 2009 Oct; 37(10 Suppl):S309-15. PubMed ID: 20046115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early short course of neuromuscular blocking agents in patients with COVID-19 ARDS: a propensity score analysis.
    Li Bassi G; Gibbons K; Suen JY; Dalton HJ; White N; Corley A; Shrapnel S; Hinton S; Forsyth S; Laffey JG; Fan E; Fanning JP; Panigada M; Bartlett R; Brodie D; Burrell A; Chiumello D; Elhazmi A; Esperatti M; Grasselli G; Hodgson C; Ichiba S; Luna C; Marwali E; Merson L; Murthy S; Nichol A; Ogino M; Pelosi P; Torres A; Ng PY; Fraser JF;
    Crit Care; 2022 May; 26(1):141. PubMed ID: 35581612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuromuscular blockers and ARDS.
    Devlin JW; Garpestad E; Hill NS
    N Engl J Med; 2010 Dec; 363(26):2562; author reply 2563-4. PubMed ID: 21175322
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacoeconomic issues of sedation, analgesia, and neuromuscular blockade in critical care.
    Armstrong DK; Crisp CB
    New Horiz; 1994 Feb; 2(1):85-93. PubMed ID: 7922434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What Is the Evidence for Harm of Neuromuscular Blockade and Corticosteroid Use in the Intensive Care Unit?
    Annane D
    Semin Respir Crit Care Med; 2016 Feb; 37(1):51-6. PubMed ID: 26820274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tachyphylaxis to cisatracurium--case reports and literature review.
    Haddad S
    Middle East J Anaesthesiol; 2008 Jun; 19(5):1079-92. PubMed ID: 18637607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of neuromuscular blocking agents on gas exchange in patients presenting with acute respiratory distress syndrome.
    Gainnier M; Roch A; Forel JM; Thirion X; Arnal JM; Donati S; Papazian L
    Crit Care Med; 2004 Jan; 32(1):113-9. PubMed ID: 14707568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effect of neuromuscular blocking agents on prognosis of patients with acute respiratory distress syndrome: a meta analysis].
    Wang AT; Gao JL; Li XL; Leng YX; Yao ZY; Zhu X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Mar; 25(3):149-53. PubMed ID: 23656767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonconventional support of respiration.
    Patroniti N; Bellani G; Pesenti A
    Curr Opin Crit Care; 2011 Oct; 17(5):527-32. PubMed ID: 21825975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuromuscular Blockade in the 21st Century Management of the Critically Ill Patient.
    deBacker J; Hart N; Fan E
    Chest; 2017 Mar; 151(3):697-706. PubMed ID: 27818334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intensive Care Nurses' Knowledge About Use of Neuromuscular Blocking Agents in Patients With Respiratory Failure.
    Frazee EN; Personett HA; Bauer SR; Dzierba AL; Stollings JL; Ryder LP; Elmer JL; Caples SM; Daniels CE
    Am J Crit Care; 2015 Sep; 24(5):431-9. PubMed ID: 26330436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes of acute respiratory distress syndrome (ARDS) in elderly patients.
    Eachempati SR; Hydo LJ; Shou J; Barie PS
    J Trauma; 2007 Aug; 63(2):344-50. PubMed ID: 17693834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome.
    Steinberg KP; Hudson LD; Goodman RB; Hough CL; Lanken PN; Hyzy R; Thompson BT; Ancukiewicz M;
    N Engl J Med; 2006 Apr; 354(16):1671-84. PubMed ID: 16625008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Continuous-infusion neuromuscular blocking agents in critically ill neonates and children.
    Johnson PN; Miller J; Gormley AK
    Pharmacotherapy; 2011 Jun; 31(6):609-20. PubMed ID: 21923445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.